Search - tctmd.com

Displaying 241 - 260 of 23691

Sort: Relevancy | Date

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

BRS in Saphenous Vein Grafts With OCT Guidance (OCTOPUS Registry Results and Case Examples)

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Wojtek Wojakowski

November 01, 2016

Presentation TCT 2016

Le Ballon Ne Passe Pas/The Ballon Doesnt Go/CTO Perspectives

Presenter: Bernard R. Chevalier, Philippe Généreux, Stéphane Rinfret

November 01, 2016

Presentation TCT 2016

HVAD & MVAD

Presenter: Daniel Burkhoff, Yoshifumi Naka, Palak Shah

November 01, 2016

Presentation TCT 2016

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Presentation TCT 2016

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

Presenter: Aaron V. Kaplan, Rachel Neubrander, Tamara Syrek Jensen

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 4: Tricuspid MitraClip Procedure, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian

November 01, 2016

Presentation TCT 2016

Valve Selection for TAVR: Similarities and Differences; How to Choose

Presenter: Ziyad M. Hijazi, David W.M. Muller, Mohamed Chettibi

November 01, 2016

Presentation TCT 2016

Angiographic Coregistration of IVUS, OCT, FFR, iFR, and More

Presenter: Adrian P. Banning, Ryan D. Madder, Giulio Guagliumi

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Cheng-Han Chen

November 01, 2016

Presentation TCT 2016

My Worst Complication (s) of the Last Year

Presenter: Talib Majwal, Barry D. Rutherford, Gerald S. Werner, J. Aaron Grantham

November 01, 2016

Presentation TCT 2016

Overview of Subclavian and Innominate Artery Interventions

Presenter: William A. Gray, Mehdi H. Shishehbor, Jacques Busquet

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Follow-up Evaluation After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw, Bushra S Rana

November 01, 2016

Presentation TCT 2016

BRS STEMI Rapid-Fire Case Reviews

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Arif Al Nooryani

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 3: Forma Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Role of Echocardiography in TAVR

Presenter: Ziyad M. Hijazi, David W.M. Muller, Muhamed Saric

November 01, 2016

Presentation TCT 2016

Bifurcations et Trifurcations Avec Angles Extrèmes/Extreme Angulation Bifurcation

Presenter: Bernard R. Chevalier, Philippe Généreux, Yves R. Louvard

November 01, 2016

Presentation TCT 2016

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant

November 01, 2016

Advertisement

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

BRS in Saphenous Vein Grafts With OCT Guidance (OCTOPUS Registry Results and Case Examples)

Le Ballon Ne Passe Pas/The Ballon Doesnt Go/CTO Perspectives

HVAD & MVAD

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

Transcatheter Tricuspid Valve Therapies 4: Tricuspid MitraClip Procedure, Results and a Case

Valve Selection for TAVR: Similarities and Differences; How to Choose

Angiographic Coregistration of IVUS, OCT, FFR, iFR, and More

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

My Worst Complication (s) of the Last Year

Overview of Subclavian and Innominate Artery Interventions

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Follow-up Evaluation After LAA Closure

BRS STEMI Rapid-Fire Case Reviews

Transcatheter Tricuspid Valve Therapies 3: Forma Description, Results and a Case

Role of Echocardiography in TAVR

Bifurcations et Trifurcations Avec Angles Extrèmes/Extreme Angulation Bifurcation

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content